Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018927 · ClinicalTrials.gov registry record
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
A clinical trial, sponsored by University of Arkansas.
- Terminated
- Registry status
- 44
- Enrollment target
NCT01018927: Clinical Trial study, sponsored by University of Arkansas.
NCT01018927 is a clinical trial that was terminated before completion, run by University of Arkansas. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01018927 was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.
Interventions
- DEVICE Administering three additional MRI images
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-05-30 |
Why NCT01018927 stopped before completion
NCT01018927 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Administering three additional MRI images is the first listed.
NCT01018927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01018927 about?
NCT01018927 is a clinical study titled "Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects". The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.
What is the current status of trial NCT01018927?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2009-06. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT01018927?
The interventions under investigation include: Administering three additional MRI images (DEVICE).
Who is sponsoring clinical trial NCT01018927?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia